Latest Therapeutics Jobs

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML and quantitative systems pharmacology methods, and defends results to governance boards and regulators. Sits within Oncology Translational Medicine's Clinical Pharmacology Modelling and Simulation group, working across small molecules, biologics and antibody drug conjugates.

GSK London £119,250 – £198,750 pa

Hybrid

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML, quantitative systems pharmacology and model-based meta-analysis to small molecules, biologics and antibody drug conjugates. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

GSK Wavre, Belgium €119,250 – €198,750 pa

Hybrid

Medical Director, Oncology Clinical Development - Lung & Head/Neck Cancers

Serves as the physician within oncology clinical programme teams, leading medical monitoring and safety oversight for lung and head/neck cancer studies. Interprets clinical and safety data, contributes to protocol development, and engages investigators, regulators and cross-functional matrix teams across Phase I–III development.

GSK Mississauga, Canada US$222,750 – US$371,250 pa

On-site

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development of oncology assets in genitourinary cancers, overseeing Phase 1-3 interventional trials from protocol design through final study report. Provides real-time medical monitoring, safety review with pharmacovigilance, and regulatory document authoring, while building relationships with key external experts. Serves as a core member of the Clinical Matrix Team and contributes to disease area strategy and business development diligence.

GSK London US$284,250 – US$473,750 pa

On-site

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds relationships with key external experts and represents the company at advisory boards and medical meetings.

GSK Waltham, United States US$284,250 – US$473,750 pa

On-site

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

GSK Stevenage US$284,250 – US$473,750 pa

On-site

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development for GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

GSK Zug, Switzerland US$284,250 – US$473,750 pa

On-site

Executive Medical Director, Clinical Development Lead - Oncology GU

Owns the clinical strategy, scientific narrative and benefit-risk framework for a genitourinary oncology asset across its lifecycle, acting as the senior clinical authority within the Medicine Development Team core quad. Directs study-level delivery through Senior Scientists, leads governance and Health Authority interactions, and applies AI-enabled analytics to sharpen development decisions. Also mentors clinical development talent and shapes standards across Oncology Clinical Development.

GSK Mississauga, Canada US$284,250 – US$473,750 pa

Hybrid

Executive Medical Director, Clinical Development Lead - Oncology GU

Owns the clinical strategy, scientific narrative and benefit-risk framework for genitourinary oncology assets, acting as the senior clinical authority on the Medicine Development Team core quad. Sets asset-level evidence-generation and governance strategy while Senior Scientists lead operational study delivery, and represents Clinical Development in health authority, advisory board and alliance interactions. Distinct for its enterprise-level scope, AI-enabled decision-making and people leadership across the oncology portfolio.

GSK London

Hybrid

Executive Medical Director, Clinical Development Lead - Oncology GU

Enterprise-level clinical strategy leader for a genitourinary oncology asset, owning the clinical roadmap, benefit-risk framework and scientific narrative across the lifecycle. Acts as the clinical authority on the Medicine Development Team core quad, representing Clinical Development in governance, health authority interactions and alliance partnerships, while directing Senior Scientists who handle study-level delivery. Distinct for its heavy emphasis on AI-enabled insights, advanced analytics and decision velocity.

GSK Warsaw, Poland PLN 593,250 – PLN 988,750 pa

Hybrid

Executive Medical Director, Clinical Development Lead - Oncology GU

Enterprise-level clinical strategy leader for a genitourinary oncology asset, owning the clinical roadmap, benefit-risk framework and governance/investment decisions across the lifecycle. Sits on the Medicine Development Team core quad, represents Clinical Development in Health Authority interactions and external engagements, and directs Senior Scientists who handle study-level delivery. Distinct for its asset-level strategic accountability and emphasis on AI-enabled insights and advanced analytics.

GSK Grimsby US$284,250 – US$473,750 pa

Hybrid

Executive Medical Director, Clinical Development Lead - Oncology GU

Owns the clinical strategy, scientific narrative and benefit-risk framework for a genitourinary oncology asset, acting as the senior clinical authority on the Medicine Development Team core quad. Sets asset-level evidence generation and governance direction while study-level delivery is led by Senior Scientists, and represents Clinical Development in Health Authority interactions, advisory boards and alliance partnerships. Uses AI-enabled insights and advanced analytics to sharpen development decisions and mentors clinical development talent.

GSK Stevenage

Hybrid

Medical Director, Oncology Clinical Development - GU

Serves as the physician within an oncology clinical program team, leading medical monitoring and safety oversight for genitourinary cancer studies. Interprets clinical and safety data, contributes to protocol development and regulatory interactions, and acts as a core member of the Clinical Matrix Team. Hybrid role requiring on-site presence at least two days per week.

GSK Zug, Switzerland US$189,750 – US$316,250 pa

Hybrid

Chemical Sciences Industrial Placement, 2027

A 12-month industrial placement within GSK's Manufacturing Science and Technology group, working on live pharmaceutical projects across analytical chemistry, synthetic organic chemistry or materials science. Placements involve instrumental analysis (HPLC, GC, NMR, SEM), process support and troubleshooting, method validation and GMP/GDP documentation, with full-time on-site working at Montrose or Ware.

GSK Ware £26,400 pa

On-site Internship

Medical Director, Oncology Clinical Development - GU

Serves as the physician within a clinical program team, leading medical monitoring and safety oversight for genitourinary oncology studies. Interprets clinical and safety data, contributes to protocol development and regulatory interactions, and acts as a core member of the Clinical Matrix Team. Hybrid role requiring on-site presence at least two days per week.

GSK Waltham, United States US$189,750 – US$316,250 pa

Hybrid